Serum and supplement optimization for EU GMP-compliance in cardiospheres cell culture. - Wikidata - awgldk - TriplyDB

Serum and supplement optimization for EU GMP-compliance in cardiospheres cell culture.

Serum and supplement optimization for EU GMP-compliance in cardiospheres cell culture.

http://www.wikidata.org/entity/Q37724023

about

Patient-Specific Age: The Other Side of the Coin in Advanced Mesenchymal Stem Cell Therapy State of the Art on the Evidence Base in Cardiac Regenerative Therapy: Overview of 41 Systematic Reviews Foetal bovine serum-derived exosomes affect yield and phenotype of human cardiac progenitor cell culture Β-blockers treatment of cardiac surgery patients enhances isolation and improves phenotype of cardiosphere-derived cells.Endothelial and smooth muscle cells derived from human cardiac explants demonstrate angiogenic potential and suitable for design of cell-containing vascular grafts.Multidisciplinary approaches to stimulate wound healing.Stem Cell Spheroids and Ex Vivo Niche Modeling: Rationalization and Scaling-Up.Influence of Egr-1 in cardiac tissue-derived mesenchymal stem cells in response to glucose variations.Normal versus Pathological Cardiac Fibroblast-Derived Extracellular Matrix Differentially Modulates Cardiosphere-Derived Cell Paracrine Properties and Commitment The potential of GMP-compliant platelet lysate to induce a permissive state for cardiovascular transdifferentiation in human mediastinal adipose tissue-derived mesenchymal stem cells.Bridging the Gap between Translational and Outcome Research in Cardiovascular Disease Sex Differences of Human Cardiac Progenitor Cells in the Biological Response to TNF-α Treatment.Effects of different concentrations of Platelet-rich Plasma and Platelet-Poor Plasma on vitality and differentiation of autologous Adipose tissue-derived stem cells.

P2860

Q26773103-C8F7091F-328C-49AA-80FB-96E025607F8B Q26801502-F21D2119-0FCE-4940-AD9C-B563A0FC19E3 Q37027746-ACC4BC5C-777A-42D3-AF61-ECABEFC23D65 Q37411881-B6872496-44F2-4E5A-A261-BC10DEE86ECF Q37680222-FDA348BE-1AA9-45E6-A98F-41292490EF08 Q38840107-9BDD5542-0F95-41F1-9736-3136814491CB Q39177046-F163671F-A45F-4E98-A8F9-A66FEE9BEEB0 Q40615780-EAF0735C-B291-4D99-AA9F-549CAFD953FF Q40979831-D7A24AEE-5AC1-4CCB-B790-3694587C0D45 Q41901872-6F0C7520-DE07-4783-A0CF-DA5DA147B853 Q42060323-F05DEB7B-E158-4431-B0FD-201ED8AB2F09 Q47104911-C64B1FE0-81C1-4420-A07F-959EB9379E2F Q50214114-491E33AA-FA83-4122-B276-1DC8031DC046

P2860

Serum and supplement optimization for EU GMP-compliance in cardiospheres cell culture.

http://www.wikidata.org/entity/Q37724023

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 20 January 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Serum and supplement optimization for EU GMP-compliance in cardiospheres cell culture.

@en

Serum and supplement optimization for EU GMP-compliance in cardiospheres cell culture.

@nl

type

label

Serum and supplement optimization for EU GMP-compliance in cardiospheres cell culture.

@en

Serum and supplement optimization for EU GMP-compliance in cardiospheres cell culture.

@nl

prefLabel

Serum and supplement optimization for EU GMP-compliance in cardiospheres cell culture.

@en

Serum and supplement optimization for EU GMP-compliance in cardiospheres cell culture.

@nl

P1433

Q37724023-14D85263-2A30-4D13-980D-B21F2C414A51

P1476

Q37724023-902599E4-8BDC-4F04-8876-9461843B64E0

P2093

Q37724023-379BF455-B310-408D-BC70-B6CCA0C973C2

Q37724023-44262723-9C5A-48A8-AE15-A5EFD3228A1B

Q37724023-5832AF22-FDF8-461A-8E40-5F5551170FA2

Q37724023-9974CF94-24D3-49EC-B184-90D20C2BBD98

Q37724023-FF28D220-1522-44A3-8768-E420D55C72A5

P2860

Q37724023-0579A6F4-9C51-464A-BB2A-B19CF0DABEEB

Q37724023-0CE5CDB8-8CA1-468E-AB06-78836829AC61

Q37724023-0E073587-BD92-4E3B-BC1F-F907CCA74B24

Q37724023-10215650-6957-4F2D-9F06-95F7AF49A89D

Q37724023-112E71E9-D4F9-432C-9BE0-BA019C53AD63

Q37724023-19447649-DE91-4B7A-9020-7B488D303FE3

Q37724023-1CBC08B4-F114-4F6B-A6B6-39F92036262B

Q37724023-1F68A6AB-6788-4FB2-85DE-7F7CB0171D28

Q37724023-32851360-637E-474A-92CE-22757F5D0D72

Q37724023-33754C10-37F6-4BDB-A1DD-79B45E47F50E

P304

Q37724023-2EFE4378-F8AD-44D4-AB50-5FDEDF35C5B6

P31

Q37724023-EC86AC34-1323-4B35-AE91-C5729142F4F8

P356

Q37724023-B5038417-6C53-4C15-B38E-EF1AF0CE6C19

P433

Q37724023-22DC671C-3EBF-4950-9A41-0998D1C1278E

P478

Q37724023-02456008-46CC-4709-8AFE-C9A40A43AA07

P50

Q37724023-2EE549DB-DA84-4E3D-A1B5-8B4B0157B452

Q37724023-6F520497-2DE2-472D-B3B2-40809C8B0AEB

Q37724023-94CD062A-E3D0-403B-92DE-178CA2CDD82A

Q37724023-B84960B8-769F-4710-92DD-76006813AD86

P577

Q37724023-4949014F-746F-4870-9563-C9D70F5ABADC

P5875

Q37724023-C3175F3D-93D4-4ACA-B66F-DF92A3AA92F8

P698

Q37724023-98D0F830-A21A-466F-96A6-635043B721C2

P932

Q37724023-07C2AD0D-30DC-482A-AF87-0F3D6C12CE5F

P356

P1433

Journal of Cellular and Molecular Medicine

P1476

Serum and supplement optimization for EU GMP-compliance in cardiospheres cell culture.

@en

P2093

Alessandro Giacomello

http://www.w3.org/2001/XMLSchema#string

Elena De Falco

http://www.w3.org/2001/XMLSchema#string

Giuseppe Biondi Zoccai

http://www.w3.org/2001/XMLSchema#string

Isotta Chimenti

http://www.w3.org/2001/XMLSchema#string

Roberto Gaetani

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of valid housekeeping genes for quantitative RT-PCR analysis of cardiosphere-derived cells preconditioned under hypoxia or with prolyl-4-hydroxylase inhibitors

Stem cell therapy in heart diseases: a review of selected new perspectives, practical considerations and clinical applications

The stuttering progress of cell therapy for heart disease

Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial

Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial

Neural stem cell engraftment and myelination in the human brain.

N-glycolylneuraminic acid xenoantigen contamination of human embryonic and mesenchymal stem cells is substantially reversible.

Enhancement of survival of stored dopaminergic cells and promotion of graft survival by exposure of human fetal nigral tissue to glial cell line--derived neurotrophic factor in patients with Parkinson's disease. Report of two cases and technical con

GMP-compliant isolation and large-scale expansion of bone marrow-derived MSC.

Isolation and characterization of human dental pulp derived stem cells by using media containing low human serum percentage as clinical grade substitutes for bovine serum.

P304

624-634

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JCMM.12210

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

Francesco Angelini

P577

2014-01-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259824983

http://www.w3.org/2001/XMLSchema#string

P698

24444305

http://www.w3.org/2001/XMLSchema#string

P932

4000114

http://www.w3.org/2001/XMLSchema#string